Menu Back toSession-8-Implementation-of-the-Health-Canada-Requirements-of-Public-Release-of-Clinical-Information

Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest global requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.


Session 8: Oral Abstract Presentations

Session Chair(s)

Kelly  Coulbourne

Kelly Coulbourne

  • Director, Clinical Trial Disclosure and Data Transparency
  • Arena Pharmaceuticals, United States
Presentation addressing a specific topic

Speaker(s)

Chris  Pfitzer, MA

When Innovation Meets Regulation: Patient Centric Study Registration

Chris Pfitzer, MA

  • Transparency Operations Lead
  • UCB Biosciences, United States
Oladayo  Oyelola, PhD

Managing Privacy Obligations in Global Clinical Trial Transparency and Data Sharing Compliance Operations

Oladayo Oyelola, PhD

  • Senior Director, Clinical Trial Information Disclosure
  • Daiichi Sankyo, Inc., United States
Niem-Tzu Rebecca  Chen, MEd, MS

Cultivating a Culture of Compliance with Clinical Trials Disclosure on ClinicalTrials.gov

Niem-Tzu Rebecca Chen, MEd, MS

  • Human Subjects Protection Senior Analyst
  • Rutgers, The State University of New Jersey, United States
Rebecca  Li, PhD

VIVLI - Experiences in Data Sharing of Participant Level Data

Rebecca Li, PhD

  • EXECUTIVE DIRECTOR
  • Vivli Center for Global Clinical Research Data, United States